News Archives - Page 2 of 2 - Orlucent

News

Orlucent® Featured in Clinical Lab Products Magazine

February 14, 2024

Orlucent® Demonstrates Accurate, Non-Invasive Detection In Vivo of Melanoma-Related Activity Using First-in-Kind Handheld Imaging System

January 16, 2024

Orlucent® Achieves Renewal of ISO 13485:2016 Certification

December 17, 2023

Discovery of Distinctive Set of Gene Expression Patterns Changes Understanding of Atypical Mole Development and Early Melanoma

June 22, 2023

Orlucent® Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System

May 25, 2023

Registered Trademark Granted to Orlucent®

January 23, 2023

AMA Issues Category III CPT Code for Fluorescent Molecular Imaging

May 9, 2021

Orlucent® Receives California Food and Drug Branch Manufacturing License

March 11, 2021

Orlucent® Achieves ISO 13485 Certification

December 11, 2020

Orlucent® Obtains CE Marking for its Noninvasive Mole Evaluation System

April 5, 2018